shutdown News
Most Popular shutdown Story
Genzyme plant shutdown spells Protalix opportunity
As a result of the mid-June Genzyme plant shutdown, which brought a halt to the manufacture of enzyme-replacement treatments Cerezyme and Fabrazyme for Gaucher disease and Fabry disease, Read more...
Latest Headlines
- January 4, 2012
- November 21, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
